Busque entre los 166288 recursos disponibles en el repositorio
Mostrar el registro sencillo del ítem
dc.date.accessioned | 2019-11-27T17:35:53Z | |
dc.date.available | 2019-11-27T17:35:53Z | |
dc.date.issued | 2015 | |
dc.identifier.uri | http://sedici.unlp.edu.ar/handle/10915/86202 | |
dc.description.abstract | Genome integrity is continuously challenged by the DNA damage that arises during normal cell metabolism. Biallelic mutations in the genes encoding the genome surveillance enzyme ribonuclease H2 (RNase H2) cause Aicardi-Goutières syndrome (AGS), a pediatric disorder that shares features with the autoimmune disease systemic lupus erythematosus (SLE). Here we determined that heterozygous parents of AGS patients exhibit an intermediate autoimmune phenotype and demonstrated a genetic association between rare RNASEH2 sequence variants and SLE. Evaluation of patient cells revealed that SLE- and AGS-associated mutations impair RNase H2 function and result in accumulation of ribonucleotides in genomic DNA. The ensuing chronic low level of DNA damage triggered a DNA damage response characterized by constitutive p53 phosphorylation and senescence. Patient fibroblasts exhibited constitutive upregulation of IFN-stimulated genes and an enhanced type I IFN response to the immunostimulatory nucleic acid polyinosinic:polycytidylic acid and UV light irradiation, linking RNase H2 deficiency to potentiation of innate immune signaling. Moreover, UV-induced cyclobutane pyrimidine dimer formation was markedly enhanced in ribonucleotide-containing DNA, providing a mechanism for photosensitivity in RNase H2-associated SLE. Collectively, our findings implicate RNase H2 in the pathogenesis of SLE and suggest a role of DNA damage-associated pathways in the initiation of autoimmunity. | en |
dc.format.extent | 413-424 | es |
dc.language | en | es |
dc.subject | Aicardi Syndrome | es |
dc.subject | Mutation | es |
dc.subject | Syndrome AGS | es |
dc.title | Defective removal of ribonucleotides from DNA promotes systemic autoimmunity | en |
dc.type | Articulo | es |
sedici.identifier.other | doi:10.1172/JCI78001 | es |
sedici.identifier.other | eid:2-s2.0-84920413492 | es |
sedici.identifier.issn | 0021-9738 | es |
sedici.creator.person | Chara, Osvaldo | es |
sedici.description.note | La lista completa de autores que integran el documento puede consultarse en el archivo | es |
sedici.subject.materias | Biología | es |
sedici.description.fulltext | true | es |
mods.originInfo.place | Instituto de Física de Líquidos y Sistemas Biológicos | es |
sedici.subtype | Articulo | es |
sedici.rights.license | Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) | |
sedici.rights.uri | http://creativecommons.org/licenses/by-nc-sa/4.0/ | |
sedici.description.peerReview | peer-review | es |
sedici.relation.journalTitle | Journal of Clinical Investigation | es |
sedici.relation.journalVolumeAndIssue | vol. 125, no. 1 | es |
sedici.rights.sherpa | * Color: green * Pre-print del autor: can * Post-print del autor: can * Versión de editor/PDF:can * Condiciones: >>Authors personal websites, institutional repositories and funding-body repositories, including PubMed Central >>Published source must be acknowledged >>Author's pre-print must be updated with must link to publisher version with DOI >>Please use publisher PDF >>Cannot appear before publication >>If funding agency requires, authors may use a Creative Commons Attribution License >>Publisher deposits all articles in PubMed Central >>All titles are open access journals >>Publisher last reviewed on 03/06/2016 * Link a Sherpa: http://sherpa.ac.uk/romeo/issn/0021-9738/es/ |